4//SEC Filing
Bandari Jathin 4
Accession 0001213900-23-004079
CIK 0001359931other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:00 PM ET
Size
7.5 KB
Accession
0001213900-23-004079
Insider Transaction Report
Form 4
Bandari Jathin
Chief Medical Officer
Transactions
- Award
Common Stock
2023-01-19+20,700→ 39,142 total - Award
Stock Option (Right to Buy)
2023-01-19+124,400→ 124,400 totalExercise: $3.02Exp: 2033-01-18→ Common Stock (124,400 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2023.
- [F2]25% of the shares vest on the one year anniversary of January 19, 2023 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001903622
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:00 PM ET
- Size
- 7.5 KB